Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors

被引：0
|
作者：
Hebin Che
Qi Xiong
Jinxia Ma
Shixue Chen
Huan Wu
Hongli Xu
Baicun Hou
机构：
[1] Chinese PLA General Hospital,Medical Big Data Research Center
[2] Health Service Department of the Guard Bureau of the Joint Staff Department,Department of Gastroenterology
[3] The Second Medical Center,Department of Oncology
[4] Chinese PLA General Hospital and National Clinical Research Center for Geriatrics Diseases,undefined
[5] The First Affiliated Hospital of ChongQing Medical University,undefined
来源：
BMC Cancer | / 22卷
关键词：
Advanced gastric cancer; Immune checkpoint inhibitors; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors
    Che, Hebin
    Xiong, Qi
    Ma, Jinxia
    Chen, Shixue
    Wu, Huan
    Xu, Hongli
    Hou, Baicun
    BMC CANCER, 2022, 22 (01)
  • [2] Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
    Yu, Bingting
    Peppelenbosch, Maikel
    Fuhler, Gwenny
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
  • [3] Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
    Magahis, Patrick T.
    Maron, Steven B.
    Cowzer, Darren
    King, Stephanie
    Schattner, Mark
    Janjigian, Yelena
    Faleck, David
    Laszkowska, Monika
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (10)
  • [4] Association of the pretreatment lung immune prognostic index with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors
    Hou, Baicun
    Wang, Peng
    Liu, Tingting
    Chen, Shixue
    Li, Tao
    Zhang, Sujie
    Tao, Haitao
    Li, Xiaoyan
    Hu, Yi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (05)
  • [5] IMPACT OF HELIOBACTER PYLORI INFECTION STATUS ON OUTCOMES AMONG GASTRIC CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Magahis, Patrick T.
    Maron, Steven B.
    King, Stephanie
    Schattner, Mark A.
    Janjigian, Yelena
    Faleck, David M.
    Laszkowska, Monika
    GASTROENTEROLOGY, 2023, 164 (06) : S106 - S107
  • [6] Impact of helicobacter pylori infection status on outcomes among patients with gastric cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis
    de Moraes, Francisco Cezar Aquino
    Sobreira, Luis Eduardo Rodrigues
    Kelly, Francinny Alves
    Burbano, Rommel Mario Rodriguez
    MICROBIAL PATHOGENESIS, 2025, 202
  • [7] Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors
    Tonneau, Marion
    Nolin-Lapalme, Alexis
    Kazandjian, Suzanne
    Auclin, Edouard
    Panasci, Justin
    Benlaifaoui, Myriam
    Ponce, Mayra
    Al-Saleh, Afnan
    Belkaid, Wiam
    Naimi, Sabrine
    Mihalcioiu, Catalin
    Watson, Ian
    Bouin, Mickael
    Miller, Wilson
    Hudson, Marie
    Wong, Matthew K.
    Pezo, Rossanna C.
    Turcotte, Simon
    Belanger, Karl
    Jamal, Rahima
    Oster, Paul
    Velin, Dominique
    Richard, Corentin
    Messaoudene, Meriem
    Elkrief, Arielle
    Routy, Bertrand
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [8] Complete response and survival outcomes in patients with advanced cancer on immune checkpoint inhibitors
    Kartolo, Adi
    Yeung, Cynthia
    Hopman, Wilma
    Fung, Andrea S.
    Baetz, Tara
    Badillo, Francisco E. Vera
    IMMUNOTHERAPY, 2022, 14 (10) : 777 - 787
  • [9] Association of the LIPI With Survival and Response in Advanced NSCLC Patients Treated With Immune Checkpoint Inhibitors
    Zhi, X.
    Zhang, Z.
    Li, W.
    Yan, X.
    Zhang, F.
    Han, X.
    Yuan, F.
    Ma, J.
    Wang, L.
    Tao, H.
    Li, X.
    Zhang, S.
    Ge, X.
    Hu, Y.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S582 - S582
  • [10] Association of inflammatory markers with survival in patients with advanced gastric cancer treated with immune checkpoint inhibitors combined with chemotherapy as first line treatment
    Wan, Mingyu
    Ding, Yongfeng
    Mao, Chenyu
    Ma, Xiaolu
    Li, Ning
    Xiao, Cheng
    Qian, Jiong
    Jiang, Haiping
    Zheng, Yulong
    Wu, Luntao
    Teng, Lisong
    Xu, Nong
    FRONTIERS IN ONCOLOGY, 2022, 12
12345